Trial be done in combo with European regulators. Expected to begin late 2008, 52 week trial and 300 patients. That would mean reporting early 2010 I guess (not stated), but it reads like the trial carries with it pre-approval from FDA that the elements meet their critieria for approval should the trial be a success. Guess this is good news (europe and US covered in one hit). Some time to go, but there's now some certainty in the way forward for this. Is that how others read this? Hopefully the market likes the news.
- Forums
- ASX - By Stock
- regulatory path for bronchitol established
Trial be done in combo with European regulators. Expected to...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
Add SNT (ASX) to my watchlist
|
|||||
Last
3.8¢ |
Change
0.003(8.57%) |
Mkt cap ! $41.79M |
Open | High | Low | Value | Volume |
3.6¢ | 3.9¢ | 3.6¢ | $23.46K | 630.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 483610 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 91080 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 40000 | 0.040 |
2 | 106514 | 0.037 |
2 | 225000 | 0.036 |
1 | 498861 | 0.035 |
1 | 120000 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 234689 | 1 |
0.037 | 27054 | 1 |
0.038 | 250000 | 1 |
0.039 | 118000 | 2 |
0.040 | 565145 | 3 |
Last trade - 10.16am 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
SNT (ASX) Chart |